UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss
Press Release July 1st, 2025
Press Release July 1st, 2025
Otology & Neurotology February 24th, 2025
PLOS One February 19th, 2025
Press Release January 14th, 2025
Press Release November 11th, 2024
ENT and Audiology News September 3rd, 2024
The BioIndustry Association (BIA) July 23rd, 2024
ENT and Audiology News July 5th, 2024
Press Release July 2nd, 2024
Labiotech May 31st, 2024
Rinri Therapeutics Ltd.
Innovation Centre
217 Portobello
Sheffield S1 4DP
Tel. +44 [0] 114 222 4330
Email. enquiries@rinri-therapeutics.com
© Rinri Therapeutics Ltd. All Rights Reserved. Registered number 08839972